Prospects of emerging 3D bioprinting technologies: major technology components, technology developers, and end users—Part I
Bioprinting technology aims to create 3D structures with living cells to mimic real tissue and organ functions. The process involves various additive technologies, including 3D bioprinters and bioinks. Bioinks comprise hydrogels, scaffolds, additives, growth factors, and living cells. While much of...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-04-01
|
| Series: | MGM Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/mgmj.mgmj_96_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Bioprinting technology aims to create 3D structures with living cells to mimic real tissue and organ functions. The process involves various additive technologies, including 3D bioprinters and bioinks. Bioinks comprise hydrogels, scaffolds, additives, growth factors, and living cells. While much of the technology is still in the exploratory stages, it has successfully produced living tissue, blood vessels, and bones. Research suggests the potential for bioprinting whole organs to revolutionize medical procedures. Current major business components include various types of bioprinters and advanced bioinks. Advancements in technologies such as cellular reprogramming hold the potential to enhance the development of superior bioinks, thereby enabling the fabrication of 3D bioprinted tissues. 3D bioprinting technology offers significant benefits across research, personalized medicine, and other applications. This review provides a flavor of the potential benefits of using 3D bioprinting technology in various areas of usage, including Research and Development (R&D), and its applications on a wide spectrum, including personalized medicine. |
|---|---|
| ISSN: | 2347-7946 2347-7962 |